Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What next for QALYs?

Literature DB >> 21540426

What next for QALYs?

Peter J Neumann¹.

Abstract

Mesh：

Year: 2011 PMID： 21540426 DOI： 10.1001/jama.2011.566

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Health utility elicitation: is there still a role for direct methods?

Authors: Lisa A Prosser; Scott D Grosse; Eve Wittenberg
Journal: Pharmacoeconomics Date: 2012-02-01 Impact factor: 4.981

2. Valuing children's health: whose quality of life matters?

Authors: Eve Wittenberg
Journal: Pharmacoeconomics Date: 2012-08-01 Impact factor: 4.981

Review 3. Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors: Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal: Am Health Drug Benefits Date: 2014-05

4. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.

Authors: Sounok Sen; Shi-Yi Wang; Pamela R Soulos; Kevin D Frick; Jessica B Long; Kenneth B Roberts; James B Yu; Suzanne B Evans; Anees B Chagpar; Cary P Gross
Journal: J Natl Cancer Inst Date: 2014-03-05 Impact factor: 13.506

5. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Authors: Ariel Beresniak; Antonieta Medina-Lara; Jean Paul Auray; Alain De Wever; Jean-Claude Praet; Rosanna Tarricone; Aleksandra Torbica; Danielle Dupont; Michel Lamure; Gerard Duru
Journal: Pharmacoeconomics Date: 2015-01 Impact factor: 4.981

What next for QALYs?

1. Health utility elicitation: is there still a role for direct methods?

2. Valuing children's health: whose quality of life matters?

Review 3. Current challenges in health economic modeling of cancer therapies: a research inquiry.

4. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.

5. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

6. Economic analysis of revision amputation and replantation treatment of finger amputation injuries.

7. Comparative effectiveness and child health.

Review 8. [Orphan drugs : New opportunities for the treatment of rare diseases].

Review 9. Issues in the incorporation of economic perspectives and evidence into Cochrane reviews.

Review 10. The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review.